SCHEMBL6555359

SCHEMBL6555359

CC(C)(C)OC(=O)n1cncc1C(C)(C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.38
MARK3 P27448 1/20 0.38
MAP4K2 Q12851 1/20 0.38
CAMK2B Q13554 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
BCHE P06276 1/20 0.35
GPR119 Q8TDV5 5/20 0.33
BUB1 O43683 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
CYP11B2 P19099 1/20 0.32
CKS1B P61024 1/20 0.32
SKP1 P63208 1/20 0.32
SKP2 Q13309 1/20 0.32
NR1H2 P55055 1/20 0.32
FAAH O00519 1/20 0.31
ELANE P08246 1/20 0.31
IDO1 P14902 1/20 0.31
SCD5 Q86SK9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9235001 0.84 PIM1 (0.35) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL1199490 0.78 ALDH1A1 (0.39) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL7654635 0.77 PIM1 (0.39) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL9516130 0.76 PIM1 (0.38) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL6555080 0.74 PIM1 (0.35) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL1089057 0.73 PIM1 (0.37) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL4149607 0.73 PIM1 (0.37) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL20864185 0.72 FAAH (0.43) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL16060936 0.72 PIM1 (0.36) PIM1MARK3MAP4K2CAMK2BPIM3
SCHEMBL9767895 0.72 MAPK1 (0.37) PIM1MARK3MAP4K2CAMK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0708179-B1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use LILLY CO ELI (US) 2004-12-22 EP disclosed
EP-1227151-A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use ELI LILLY AND COMPANY (US) 2002-07-31 EP disclosed
US-5512549-A ANTIDIABETIC AGENTS ELI LILLY AND COMPANY (US) 1996-04-30 US disclosed
EP-0708179-A2 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use ELI LILLY AND COMPANY (US) 1996-04-24 EP disclosed